Newer treatments for decompensated heart failure: focus on levosimendan
Ferenc FollathUniversity Hospital Zürich, Steering Group Drug Therapy, Zürich, SwitzerlandAbstract: Acute heart failure (AHF) is a major cause of hospitalizations. Severe dyspnea, pulmonary congestion and low cardiac output with peripheral vasoconstriction and renal hypoper...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-03-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/newer-treatments-for-decompensated-heart-failure-focus-on-levosimendan-a2940 |